Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Xiaflex market launch year?When is xarelto's patent set to expire roughly?How much is mebendazole?How many years does kadcyla's market exclusivity last?
See the DrugPatentWatch profile for artesunate
Short answer: there is no recommended dose reduction for artesunate in allergic cases. If a patient has a suspected or confirmed allergy to artesunate (or to artemisinins in general), artesunate should be avoided and an alternative antimalarial regimen should be used per local guidelines (e.g., IV quinidine/quinine-based therapy with doxycycline or clindamycin, or an appropriate ACT regimen if not contraindicated). Key points: - No dose reduction is advised to tolerate an allergy; the drug should be avoided. - If an allergic reaction occurs, manage per allergic reaction protocols and switch to an alternative antimalarial. - For severe malaria, follow local guidelines for alternatives to artesunate (e.g., quinidine/quinine-based regimens) and consult infectious disease or malaria specialists as needed.
Other Questions About Artesunate :